The effect of blood pressure on IAT safety and benefit and pediatric stroke outcomes based on treatment were some of the studies presented at AAN.
Studies presented during AAN 2017 highlighted acute stroke treatment and outcomes, including impact of hyperglycemia on collaterals and stroke outcome, short door-to-needle times, the effect of blood pressure on intra-arterial treatment, and outcomes in pediatric stroke.
Acute Stroke Treatment and Outcomes: AAN 2017
Impact of Hyperglycemia According to Collateral Status on Reperfusion and Outcomes inAcute Ischemic Stroke after Mechanical Thrombectomy
Does hyperglycemia impact collaterals in acute ischemic stroke?
High glucose levels were related to poor outcomes in patients with good collaterals, but had not effect on patients with poor collaterals.
Ultra-Short Door-to-Needle Times of 10 Minutes or Less in Stroke Thrombolysis â Experience from 63 Cases
What were the outcomes with ultra-short door-to-needle times (DNT)?
With pre-notification of the stroke team, DNT â¤10 minutes can be achieved safely.
The Effect of Baseline Blood Pressure on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN
Does blood pressure influence the benefit or safety of intra-arterial treatment (IAT)?
In acute ischemic stroke caused by proximal intracranial vessel occlusion, blood pressure does not affect the benefit or safety of IAT, so there is no need to withhold or delay IAT due to blood pressure.
Thrombectomy and Thrombolysis in Pediatric Acute Ischemic Stroke
What were the outcomes in pediatric acute ischemic stroke patients receiving intravenous thrombolysis (tPA) or intra-arterial thrombectomy (IAT) versus no treatment?
Pediatric patients treated with tPA had increased mortality, and tPA+/-IAT was associated with decreased discharge home, increased cost, and higher prevalence of intracerebral hemorrhage.
